https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-24 / Technol. Cancer Res. Treat. 2015 Oct;14(5):607-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-24 / Technol. Cancer Res. Treat. 2015 Oct;14(5):607-152014-11-24 00:00:002014-11-24 00:00:00Recombinant Newcastle Disease virus Expressing IL15 Demonstrates Promising Antitumor Efficiency in Melanoma Model
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-01 / EMBO Mol Med 2014 Nov;6(11):1359-70
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-01 / EMBO Mol Med 2014 Nov;6(11):1359-702014-11-01 00:00:002019-02-15 08:47:43Emerging treatment strategies for glioblastoma multiforme
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-11-01 / J. Exp. Clin. Cancer Res. 2014 Nov;33:91
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-11-01 / J. Exp. Clin. Cancer Res. 2014 Nov;33:912014-11-01 00:00:002014-11-01 00:00:00Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-15 / Mol Med Rep 2015 Jan;11(1):317-26
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-15 / Mol Med Rep 2015 Jan;11(1):317-262014-10-15 00:00:002014-10-15 00:00:00Apoptotic induction of lung adenocarcinoma A549 cells infected by recombinant RVG Newcastle disease virus (rL-RVG) in vitro
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-06 / Oncol Lett 2014 Dec;8(6):2403-2406
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-06 / Oncol Lett 2014 Dec;8(6):2403-24062014-10-06 00:00:002021-11-16 07:53:33Long-term remission of prostate cancer with extensive bone metastases upon immuno- and virotherapy: A case report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-10-06 / Int. J. Oncol. 2015 Jan;46(1):71-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-10-06 / Int. J. Oncol. 2015 Jan;46(1):71-72014-10-06 00:00:002021-11-15 16:54:44Strong T‑cell costimulation can reactivate tumor antigen‑specific T cells in late‑stage metastasized colorectal carcinoma patients: results from a phase Ⅰ clinical study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-09-26 / Cancer Gene Ther. 2014 Nov;21(11):463-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-09-26 / Cancer Gene Ther. 2014 Nov;21(11):463-712014-09-26 00:00:002019-02-15 09:21:22Intravenously injected Newcastle disease virus in non-human primates is safe to use for oncolytic virotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-09-25 / Oncol Lett 2014 Dec;8(6):2569-2576
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-09-25 / Oncol Lett 2014 Dec;8(6):2569-25762014-09-25 00:00:002014-09-25 00:00:00Effect of recombinant Newcastle disease virus transfection on lung adenocarcinoma A549 cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-09-19 / Int J Cancer 2015 Mar;136(5):E313-25
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-09-19 / Int J Cancer 2015 Mar;136(5):E313-252014-09-19 00:00:002022-09-29 14:01:04Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2014-09-19 / Int J Med Sci 2014;11(12):1240-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2014-09-19 / Int J Med Sci 2014;11(12):1240-72014-09-19 00:00:002019-02-15 09:21:21Immunomodulatory effects of Newcastle disease virus AF2240 strain on human peripheral blood mononuclear cells
